No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Will Intellia Therapeutics (NASDAQ:NTLA) Spend Its Cash Wisely?
Why Intellia Therapeutics (NTLA) Is the Worst ARK Stock to Buy According to Short Sellers
Lilly Tops Morgan Stanley's Biopharma Pick List for 2025
Express News | Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?